BioSpace News Archive

Business

ChemDiv, Context Therapeutics and Torrey Pines Investment Announce CNS Co-Development Agreement

Under the terms of the collaboration, ChemDiv will grant Context the access to its unique integrated discovery platform, while Torrey Pines Investment will invest in Context and provide network resources to support pre-commercial R&D.

November 15, 2017

·

3 min read

Policy

Macrogen’s Clinical NGS Laboratory Receives CAP Accreditation

The accreditation was based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs.

November 15, 2017

·

2 min read

Drug Development

Verseon Presents Second Anticoagulation Candidate for Clinical Trials at AHA 2017

VE-2851 shows excellent efficacy paired with low bleeding risk in preclinical testing and is expected to enter clinical trials in 2018.

November 15, 2017

·

3 min read

FDA

Noden Pharma Announces FDA Approval of Tekturna (aliskiren) Oral Pellets for the Treatment of Hypertension in Adults and Children 6 Years of Age and Older

The new formulation and pediatric indication were approved through the FDA priority review process.

November 15, 2017

·

6 min read

Drug Development

PIN Pharma Announces Initiation of its First Phase I Study

This first-in-human, proof-of-concept study is being conducted in oncology patients with solid tumors by PIN Pharma’s wholly owned Australian subsidiary, PIN Pharma Pty Ltd.

November 15, 2017

·

2 min read

Policy

3Shape Responds to Align Technology Patent Infringement Lawsuit

3Shape says the lawsuit and infringement claims are completely unfounded and without merit. 3Shape will vigorously defend itself against such claims.

November 15, 2017

·

2 min read

Business

LUNGevity Partners With ALK Positive Patient Group to Fund Lifesaving Research

The ultimate goal of the program is to transform ALK-positive lung cancer into a chronic or curable condition.

November 15, 2017

·

4 min read

FDA

FDA Approves Ultragenyx’s Treatment for Rare Genetic Enzyme Disorder

The FDA today approved Mepsevii to treat pediatric and adult patients with an inherited metabolic condition called MPS VII, also known as Sly syndrome.

November 15, 2017

·

3 min read

Aquila Diagnostic Systems Releases Independent Trial Results for Its AccutasVET Tapeworm Fecal Test

The study demonstrated that the diagnostic performance characteristics of the AccutasVET Tapeworm fecal test are clinically significant and exceed the diagnostic performance of current practices and currently available in-clinic tapeworm test kits.

November 15, 2017

·

2 min read

Genetown

Leap Therapeutics Announces $18M Private Placement Offering

Upon closing of the transaction, Leap will sell 2,958,094 shares of unregistered common stock.

November 15, 2017

·

5 min read